A Non-Responder with Subsequent Triple-Vessel CAD: Is 24 Hours of Caffeine Withdrawal Enough?
Clinical Case Study•Cardiac PET/CT A Non-Responder with Subsequent Triple-Vessel CAD:
This Is Why We Do Cardiac PET: Comparison of SPECT and PET in the Same Patient
Clinical Case Study•Cardiac PET/CT This Is Why We Do Cardiac
Epicardial CAD in a Patient with Normal Rest/Stress PET Perfusion but Abnormal Myocardial Blood Flow Reserve
Clinical Case Study•Cardiac PET/CT Epicardial CAD in a Patient with
An FDA Rejection Over Manufacturing, Not Evidence
On Target · Issue 4•Week Ending August 14, 2026 An
Pluvicto Moves Earlier as Supply Base Consolidates
On Target · Issue 3•Week Ending August 7, 2026 Pluvicto
Fewer PSMA Suppliers, Tighter Therapy Timing Windows
On Target · Issue 2•Week Ending July 31, 2026 Fewer
Radioligand Volume Is Scaling Faster Than Screening
On Target · Issue 1•Week Ending July 24, 2026 Radioligand
ASNC says PET is now the preferred nuclear imaging test for CAD
The American Society of Nuclear Cardiology (ASNC) has shared its official
Molecular Imaging Services Appoints Christopher Pusey as Chief Executive Officer
Newark, Delaware, January 26, 2026 – Molecular Imaging Services (MIS),
Molecular Imaging Services Appoints Diana Errico as Director of Strategic Service Lines
Newark, Delaware, January 14, 2026 – Molecular Imaging Services (MIS) today